AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY METHOD TO MEASURE HUMAN APOLIPOPROTEIN-E LEVELS USING COMMERCIALLY AVAILABLE REAGENTS - EFFECT OF APOLIPOPROTEIN-E POLYMORPHISM ON SERUM APOLIPOPROTEIN-E CONCENTRATION

被引:19
作者
GRACIA, V
FIOL, C
HURTADO, I
PINTO, X
ARGIMON, JM
CASTINEIRAS, MJ
机构
[1] CIUTAT SANITARIA & UNIV BELLVITGE,DIV BIOCHEM,BARCELONA,SPAIN
[2] CIUTAT SANITARIA & UNIV BELLVITGE,DEPT INTERNAL MED,BARCELONA,SPAIN
[3] CIUTAT SANITARIA & UNIV BELLVITGE,REG SANITARIA COSTA PONENT,BARCELONA,SPAIN
关键词
D O I
10.1006/abio.1994.1576
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and specific enzyme-linked immunosorbent assay (ELISA) for human apolipoprotein E (ape E) quantification using commercially available reagents is described. The assay is a noncompetitive, sandwich ELISA in which the wells were coated with a monoclonal EO1 antibody anti-human ape E and detected with a polyclonal antibody-peroxidase conjugate anti-apo E. The mean ape E concentration in 168 middle-aged subjects randomly selected from general population was 51.7 +/- 12.4 mg/liter. Apo E levels were highly correlated with ape E phenotypes. Apo E polymorphism, which shows a modulating effect in the catabolism of ape E containing lipoproteins, may explain a large fraction, 18.5%, of the variability of serum ape E levels in middle-aged population. Isoforms apo E2 and apo E4 have an opposite effect on the regulation of serum ape E concentrations. Individuals that express ape E2 isoform present higher ape E levels (65.5 mg/liter for ape E2/E3), whereas the average of individuals with ape E4 is lower (42.8 mg/liter for ape E4/E3) than general population. (C) 1994 Academic Press, Inc.
引用
收藏
页码:212 / 217
页数:6
相关论文
共 23 条
  • [1] BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
  • [2] BURY J, 1986, CLIN CHEM, V32, P265
  • [3] INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON APOLIPOPROTEIN-B-100 METABOLISM IN NORMOLIPEMIC SUBJECTS
    DEMANT, T
    BEDFORD, D
    PACKARD, CJ
    SHEPHERD, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1490 - 1501
  • [4] ROLE OF APOLIPOPROTEIN-E IN THE LIPOLYTIC CONVERSION OF BETA-VERY- LOW-DENSITY LIPOPROTEINS TO LOW-DENSITY LIPOPROTEINS IN TYPE-III HYPERLIPOPROTEINEMIA
    EHNHOLM, C
    MAHLEY, RW
    CHAPPELL, DA
    WEISGRABER, KH
    LUDWIG, E
    WITZTUM, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (17): : 5566 - 5570
  • [5] PLASMA APOLIPOPROTEIN A-I, A-II, B, E AND C-III CONTAINING PARTICLES IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE
    GENEST, JJ
    BARD, JM
    FRUCHART, JC
    ORDOVAS, JM
    WILSON, PFW
    SCHAEFER, EJ
    [J]. ATHEROSCLEROSIS, 1991, 90 (2-3) : 149 - 157
  • [6] INCREASED PREVALENCE OF APOLIPOPROTEIN-E4 IN TYPE-V HYPERLIPOPROTEINEMIA
    GHISELLI, G
    SCHAEFER, EJ
    ZECH, LA
    GREGG, RE
    BREWER, HB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (02) : 474 - 477
  • [7] TYPE-III HYPERLIPOPROTEINEMIA - DEFECTIVE METABOLISM OF AN ABNORMAL APOLIPOPROTEIN-E
    GREGG, RE
    ZECH, LA
    SCHAEFER, EJ
    BREWER, HB
    [J]. SCIENCE, 1981, 211 (4482) : 584 - 586
  • [8] DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
    HAVEL, RJ
    EDER, HA
    BRAGDON, JH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) : 1345 - 1353
  • [9] RADIOIMMUNOASSAY OF HUMAN ARGININE-RICH APOLIPOPROTEIN, APOPROTEIN-E - CONCENTRATION IN BLOOD-PLASMA AND LIPOPROTEINS AS AFFECTED BY APOPROTEIN-E-3 DEFICIENCY
    HAVEL, RJ
    KOTITE, L
    VIGNE, JL
    KANE, JP
    TUN, P
    PHILLIPS, N
    CHEN, GC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (06) : 1351 - 1362
  • [10] KIM MH, 1989, J LIPID RES, V30, P663